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Abstract
Introduction This study was designed to test the feasi-
bility and face validity of the composite time trade-off
(composite TTO), a new approach to TTO allowing for a
more consistent elicitation of negative health state values.
Methods The new instrument combines a conventional
TTO to elicit values for states regarded better than dead
and a lead-time TTO for states worse than dead.
Results A total of 121 participants completed the com-
posite TTO for ten EQ-5D-5L health states. Mean values
ranged from -0.104 for health state 53555 to 0.946 for
21111. The instructions were clear to 98 % of the
respondents, and 95 % found the task easy to understand,
indicating feasibility. Further, the average number of steps
taken in the iteration procedure to achieve the point of
indifference in the TTO and the average duration of each
task were indicative of a deliberate cognitive process.
Conclusion Face validity was confirmed by the high
mean values for the mild health states ([0.90) and low
mean values for the severe states (\0.42). In conclusion,
this study demonstrates the feasibility and face validity of
the composite TTO in a face-to-face standardized com-
puter-assisted interview setting.
Keywords Time trade-off  Health state values  EQ-5D 
Health-related quality of life
JEL Classification I10  I19
Introduction
The EuroQol Group has recently introduced a five-level
version of EQ-5D (EQ-5D-5L), which expands the range of
responses in each dimension from three to five levels while
retaining the five original dimensions [1]. Level descriptors
follow the same format for each dimension: no problems,
slight problems, moderate problems, severe problems, and
extreme problems/unable to. The first studies investigating
its measurement properties indicated improvement over
the EQ-5D-3L in terms of a reduced ceiling, increased
reliability, and greater ability to discriminate between dif-
ferent levels of health, while establishing convergent and
known group validity [2–5]. However, before the EQ-5D-
5L can be used to evaluate the quality-of-life benefits
associated with different health-care interventions, values
must be derived for each of the 3,125 health states described
by it.
Interim value sets for the new version have been
developed on the basis of a multi-country parallel field
study of the EQ-5D-5L and EQ-5D-3L. A mapping algo-
rithm for the two instruments allows values for EQ-5D-5L
states to be calculated using existing EQ-5D-3L value sets
[6]. However, a mapping algorithm gives just an estimation
of values based on the EQ-5D-3L values; to derive values
for the new five-level version, empirical studies are war-
ranted, conducted in representative samples of the general
population. For the past few years, the EuroQol Group has
been engaged in an extensive research program that aimed
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at the development of new valuation methodology for the
elicitation of value sets for the EQ-5D-5L [7].
Value sets for the EQ-5D-3L were mainly based on TTO
techniques [8]. For the valuation of EQ-5D-5L, the Euro-
Qol Group decided to explore the use of rank-based valu-
ation methods to gain additional information. In the past,
valuation studies based on the TTO have suffered from
their diversity: regarding how the question was framed,
varying time horizons (from 1 month to 30 years), when
time was traded, the health status of the time traded, the
health status after the time horizon, the instructions, the
iteration procedure, and so forth [9, 10]. Most EQ-5D-3L
valuation studies did not follow the same protocol; thus,
the data sets underlying the available EQ-5D-3L value sets
were not standardized. Another problem with the conven-
tional TTO method pertains to the valuation of health states
considered to be worse than dead (WTD), which yields neg-
ative values. The conventional TTO, as originally proposed by
Torrance et al. [11], often resulted in extremely negative
values. These were subsequently transformed according to
varying arbitrary rules to a scale with a minimum of -1 [12,
13]. To address the latter problem, the EuroQol Group
embarked on an extensive research program to develop new
TTO approaches by experimenting with multiple variants of
‘lead-time’ and ‘lag-time’ TTO [14–16].
To test these variants, a multinational study was held in
four countries (Canada, England, the Netherlands, and the
US), each with approximately 400 respondents [16]. One
additional study was conducted online in the Netherlands
(n = 6,222), the ‘Internet study’ [17]. The results brought a
few problems to light. First, group interviews and online
versions without the face-to-face assistance of an expert
interviewer yielded inconsistent results. Second, both the
lead- and lag-time approaches produced serious framing
effects. Apparently, the longer the lead time that was
offered, the more time the respondent traded off [16, 18]. A
large proportion used the complete time scale (i.e., lead
time plus disease time) to trade off, even for states that
were clearly not severe. Furthermore, many respondents
were evidently short-cutting the task. They probably rushed
through it because the lead- or lag-time task was confusing
when presented without the help of an interviewer. Many
respondents answered after only one or two steps in the
sequence of the iteration procedure had been used to find
the point of indifference. In the multinational study, around
60 % of the answers were given in five steps or less; in the
Internet study, over 60 % were given in four steps or less.
This type of response behavior resulted in large clusters at
value 0, which is counterintuitive, as this outcome means
that many respondents consider many states to be as bad as
being dead [17, 18].
These findings prompted the development of a ‘com-
posite’ approach, seen as the best of both worlds, that is,
the use of the conventional TTO to derive values [0 and,
for those states where all the time is traded away, the use of
a lead-time TTO to derive values \0. The purpose of the
present study was to test the feasibility and face validity of
this newly developed composite TTO.
Methods
Participants
A specialized recruitment agency was engaged to collect
the data. The interviews were conducted in Rotterdam, the
Netherlands, by trained interviewers (ES, MO, MV, and
BJ). In total, 140 persons were invited to take part, and
each was given €30 for participating.
Study design
The results of the multinational and Internet studies indi-
cated that it was not feasible to elicit TTO values in either a
group or an online setting. We therefore opted for face-to-
face interviews. The EQ-5D-5L valuation protocol was
administered in a digital setting to enable its standardiza-
tion and ensure comparability of the study results. The
protocol was presented in a computer-assisted personal
interview mode using the EuroQol Valuation Technology
(EQ-VT). The EQ-VT was translated by the same proce-
dure used for the EQ-5D instrument to maximize stan-
dardization across countries.
The participants in the current study were first asked to
fill out the EQ-5D-5L and answer a few background
questions. Next, they were given the example of a health
state, namely ‘living in a wheelchair,’ allowing the inter-
viewer to carefully explain the composite TTO task. The
purpose was to ensure that the respondents understood its
underlying rationale. After the example, ten EQ-5D-5L
health states (see Table 1) were presented for valuation by
Table 1 Composite TTO values for the ten health states (n = 121)
EQ-5D-5L
health state
Mean SD Median 95 % CI
21111 0.946 0.142 1.00 0.921 0.972
11221 0.940 0.120 1.00 0.919 0.961
12112 0.913 0.152 0.95 0.886 0.940
33133 0.814 0.182 0.85 0.782 0.846
52221 0.703 0.357 0.80 0.640 0.767
44113 0.633 0.389 0.70 0.564 0.703
52324 0.420 0.529 0.50 0.326 0.514
55523 0.245 0.589 0.45 0.140 0.350
11145 0.176 0.627 0.40 0.064 0.288
53555 -0.104 0.612 0.00 -0.213 0.005
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means of composite TTO. These were taken from one of
the blocks of the study design used in the multinational
study, and they varied in severity across the five dimen-
sions. Finally, a few debriefing questions were asked, fol-
lowing a structured interviewer protocol.
The composite time trade-off: conceptual approach
In the conventional TTO approach, the value for a health
state is derived by finding the amount of time in full health
x, which is considered equal to a given amount of time in a
less than optimal health state t, and calculating the value of
the state as x/t. In EQ-5D valuation studies, t is conven-
tionally set at 10 years. This approach, which has been
widely used in valuation studies of the EQ-5D-3L, works
well to elicit values for states that are preferred to dead
(i.e., have values between 0 and 1). As mentioned above,
the conventional TTO approach to eliciting values \0 is
problematic. A way of avoiding such problems is to simply
provide more ‘trading time’ in full health and to add a
corresponding amount of time in full health to the health
state being valued. Then, when valuing health states con-
sidered WTD, the respondents could trade off more time
for the same health state with the same duration. The
additional time can be placed either before the health state
being valued (lead-time TTO) or after it (lag-time TTO).
As mentioned above, it was evident in light of the multi-
national and Internet studies that the lead-time (and lag-time)
TTO approaches caused serious framing effects. It was also
clear that the respondents had difficulty with the task, which led
to inconsistent results [18]. These findings prompted the
development of the composite TTO approach, which distin-
guishes between better than dead (BTD) and WTD health
states by presenting these options in two separate TTO tasks.
The composite TTO used conventional TTO to elicit BTD
values, but it used lead-time TTO to elicit WTD values. All
valuation tasks commenced with the conventional TTO:
10-year duration in the state being valued (Life B) and 10 years
in full health to trade (Life A). For states that are considered very
poor, respondents may trade off all 10 years in full health; thus,
the value for that state is at best equal to 0. At that point, lead-
time TTO is introduced to elicit values \0. This is achieved
simply by giving the respondent another 10 years of trading
time in full health and, correspondingly, adding 10 years in
full health before reaching the state being valued in Life B.
The preference for lead-time over lag-time was based on
two considerations. First, lead-time TTO is conceptually
(and in practical terms, from the participants’ perspective)
more in line with the conventional TTO task. Second, the
results for lag- and lead-time were similar. Since the time
frame for the conventional TTO was set at 10 years, it was
decided to use the lead-time TTO with a ratio of 1:1, i.e.,
10 years of lead time.
Note that the WTD part of composite TTO (i.e., lead-
time TTO) is a profile method [19–21] posing one extra
assumption on the TTO results. In general, TTO assumes
constant proportional trade-off, implying that the amount
of time traded (relative to the total time horizon) is inde-
pendent of the time horizon used. Composite TTO poses
the extra assumption of additive independence [22, 23]. It
implies that the value of a health state in period T1 is
independent of the value of another health state in period
T2. Therefore, the raw TTO values have to be transformed
under the assumption that the time spent in the EQ-5D-5L
health state can simply be added to the 10 years of lead
time spent in full health. This linear solution implies that
the raw values resulting from the task are assumed to be
equal to the disease time ?10 years of full health, leading
to a necessary transformation according to the following
formula: composite TTO value = (raw value - 10)/10.
The composite time trade-off: practical approach
The initial screens for both the BTD and WTD elements of
the composite TTO EQ-VT task are depicted in Fig. 1. The
instruction text for the first screen reads as follows:
The green bar describes what we call Life A. In Life A
you will live 10 years from now—and during those
10 years you will be in full health. After the 10 years
you will die. The blue bar describes what we call Life B.
In Life B you will also live for 10 years after which you
will die. However, in these 10 years you have health
problems as described in the blue box. Try to imagine
what it would be like for someone like you to have to
choose between Life A and Life B. Which would you
choose? The choice is between Life A, 10 years of full
health, and Life B, 10 years with health problems.
For the WTD part of the task, operationalized by lead-
time TTO, the instruction text reads as follows:
Now you are being asked a slightly different sort of
question. You are still being asked to choose between
Life A and Life B; the blue bar in Life B still refers to
spending 10 years with the same health problems as
before. However, the problems in Life B no longer
begin straight away, but after 10 years in full health.
So Life B now lasts for 20 years in total from now:
10 years of full health followed by 10 years with
health problems. Life A has also changed—it now
lasts for 10 years. So you can now choose between
10 years of living in full health in Life A or 20 years
in Life B—10 years in full health followed by
10 years with health problems.
The lead-time TTO was explained in detail as part of
the example exercise. Thereby, the respondents were
Introducing the composite time trade-off S7
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encouraged to imagine a health state that was so bad that
they would prefer to die immediately. It was explicitly
stated that for the ten health states to be valued, they might
not end up in this part of the task. That is, they would not
have to perform the WTD part of the task if no health state
were considered to be WTD.
The iteration procedure determining the steps and
amount of time offered and traded in TTO (Fig. 2) was
derived from the original Measurement and Valuation of
Health protocol, on which the first EQ-5D valuation study
was based [24].
Feasibility
Feasibility of the composite TTO was assessed by a
number of debriefing questions. These inquired whether the
Fig. 1 The composite TTO
task: a Conventional TTO with
a 10-year time frame to value
states better than dead; b lead-
time TTO with a time frame of
20 years to value states worse
than dead
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instructions were clear and how difficult understanding the
task was. To assess the cognitive burden of composite
TTO, the respondents were asked how difficult it was to
determine the point of equivalence between Life A and
Life B (operationalized as: ‘‘I found it difficult to decide on
the exact point where Life A and Life B were about the
same’’). All debriefing statements were accompanied by a
five-point Likert scale with ‘agree’ and ‘disagree’ as
anchors. Since the respondents were obviously short-cut-
ting the task in the multinational and Internet studies,
feasibility was also tested by assessing the average number
of steps in the iterative sequence needed to reach a point of
indifference and the average duration of the task for one
health state.
Face validity
Face validity of composite TTO was assessed by
observing the mean values for the three milder states
(including only a level 2 on one or two dimensions) and
the four severe states (including at least one level 5 and
one level 4 or 5). The expectation was that high mean
values would be found for the mild states and low ones for
the severe states. For the three remaining ‘moderate’




A total of 121 respondents completed the composite TTO
task for all health states. The overall sample was 56 %
female and had a mean age of 42 (SD 14), ranging from 19
to 70 years. A mean EQ-VAS score of 83 (SD 13) was
observed, ranging from 21 to 100.
Mean TTO values for the ten EQ-5D-5L health states
ranged from -0.104 for health state 53555 to 0.946 for
21111 (Table 1). For the more severe states, standard
deviations were higher and distributions were skewed,
with higher medians over mean values. The average
number of steps needed to reach equivalence ranged from
6.2 for state 11145 to 8.3 for state 12112 (Table 2). The
median number of steps was 7, as opposed to a median of
5 for the multinational study and 4 for the Internet study.
The average duration of the task ranged from 54 s for
state 21111 to just under 2 min for state 12112. The
median duration was 1 min and 8 s, as opposed to a
median duration of 37 s for the multinational study and 17
for the Internet study. These findings confirmed that the
respondents avoided short-cutting the TTO task, a
behavior seen in earlier studies, and are indicative of a
deliberate cognitive process.
Feasibility
The debriefing confirmed the feasibility of the composite
TTO. According to 98 % of the respondents, the instruc-
tions for the composite TTO task made clear what they
needed to do (scoring 1 or 2 on the five-point Likert scale),
as opposed to 89 % in the multinational study and 60 % in
the Internet study. The task was easy to understand for






























Fig. 2 Iteration procedure for the composite TTO task. Numbers
indicate the time in full health. Green arrows indicate the state is
better than the previous suggestion. Red arrows indicate the state is
worse than the previous suggestion (color figure online)




N Steps SD Duration SD
21111 121 7.4 3.9 00 5400 00 4100
11221 121 7.6 3.5 00 5900 00 5100
12112 121 8.3 3.7 10 5900 10 2000
33133 121 7.1 3.1 10 2100 00 5800
52221 121 7.6 4.0 10 3700 10 0400
44113 121 6.5 2.8 10 2000 00 5800
52324 121 6.2 3.5 10 1900 10 0700
55523 121 6.3 3.2 10 2500 10 1000
11145 121 6.2 3.1 10 2100 10 0200
53555 121 7.3 3.6 10 5400 10 3600
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59 % in the Internet study. The cognitive burden of com-
posite TTO is revealed by the fact that 60 % of the
respondents found it difficult to decide where the point of
equivalence was for them.
Face validity
Face validity of the composite TTO seems to be largely
confirmed. Mean values for the three mild states were high
([0.90), they were low for the four severe states (\0.42),
and the values for the three remaining moderate states lay
in between. The patterns of the frequency distributions for
six of the ten health states were as expected, with skewed
distributions for the mild state (21111) and clusters at
values -1 and 0 for the severe health states (Fig. 3).
Face validity is also confirmed when the data from the
current study are compared to those from the multinational
and Internet studies (Fig. 4). For the mild health state
12112, there was no clustering at 0 in the current study,
whereas such clusters were clearly present in the multi-
national and Internet studies. Nor were WTD values
assigned to this mild state in the current study. For the
moderate state 33133, there was no clustering at 0, while
the clustering at 1 was much reduced. No WTD values
were given for this state. For the severe state 53555, the
clustering at 1 was almost completely gone (in contrast to
the clusters at 1 for the multinational and Internet studies),
the clustering at 0 was reduced, but a new clustering
appeared at -1, which was more in line with expectations










































Fig. 3 Frequency distributions for six EQ-5D-5L health states


































































Fig. 4 Observed frequency of responses for a mild state (12112),
moderate state (33133), and severe state (53555). For the multi-
national study, the 10–5 lead time was used, resulting in values
between -2 and 1 (results between -2 and -1 were omitted: one
respondent valued below -1 for health state 33133 and nine
respondents for health state 53555 (11%)). For the Internet study
and the current composite TTO study, the 10–10 lead time was used,
resulting in values between -1 and 1
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Discussion
This study introduced the composite time trade-off, a
newly developed TTO approach allowing for a more con-
sistent elicitation of negative values. Feasibility and face
validity were demonstrated in a sample of 121 respondents.
Mean values for ten EQ-5D-5L health states were as
expected, confirming face validity. Debriefing indicated
that respondents understood the task, thereby establishing
the feasibility of composite TTO. Furthermore, the number
of steps used to achieve indifference and the amount of
time it took the respondents to complete the composite
TTO tasks are indicative of a deliberate cognitive process.
These findings confirm that short-cutting the TTO task was
avoided, whereas short-cutting was seen in earlier studies
utilizing lead- (or lag-)time TTO approaches for both BTD
and WTD elements of the task.
The distributions of the health states show patterns
familiar for TTO, with skewed distributions for mild states
and more dispersed patterns for moderate and severe states.
Interestingly, the severe states have clusters at -1 and 0,
indicating there might be individual differences in response
behavior. Modeling exercises for the EQ-5D-5L valuation
studies might benefit from taking these subgroups into
account.
The composite TTO leads to a more consistent approach
of eliciting negative values, without the need for an arbi-
trary rescaling of values, as required for the conventional
TTO approach. In 2012, the EuroQol Group finalized the
new protocol for the valuation of the EQ-5D-5L [18], of
which the composite TTO is the cornerstone. One of its
main benefits is arguably the availability of a standardized
protocol for EQ-5D-5L valuation studies, operationalized
by the EQ-VT software and a standardized interviewer
protocol, which ensures consistency and comparability
across studies and countries.
Composite TTO, like time trade-off in general, has a
high cognitive burden, which led the EuroQol Group to opt
for a face-to-face interview setting. The presence of expert
interviewers was essential to the validity of the composite
TTO. One caveat is that the training of the interviewers is
crucial. Therefore, the EuroQol Group has made it a pri-
ority to carefully train interviewers and to monitor and
offer guidance to valuation studies. Dependency on inter-
viewers might lead to interviewer bias, a possibility that
will be monitored in ongoing valuation studies.
One limitation of the composite TTO is that it places an
extra assumption on the WTD responses. Besides constant
proportional trade-off, additive independence is now
assumed. Another limitation is that two different modes of
elicitation are used to obtain responses for BTD and WTD
health states. However, for any health state the respondent
has the option to go to the WTD part of the task. Thus, one
could reason that there is always a window of 20 years
underlying the task, without showing the first 10 years in
full health for both Life A and Life B for the BTD part of
the task. Further, sequence effects might affect the out-
comes of the lead-time TTO [25], since the 10 years in full
health always come first. However, comparing lead- and
lag-time TTO indicates that the impact is negligible [15,
16]. The ratio of lead time to disease time might have an
influence on the final TTO values, since some respondents
may want to trade off more time than the maximum
available amount. Finally, lead-time TTO experiments
suggest that this ratio is related to a framing effect and that
long lead times are ill advised. Further research is needed
on techniques to model these ‘censored’ values.
In conclusion, the present study introduced the com-
posite TTO and demonstrated its feasibility and face
validity in a face-to-face standardized computer-assisted
interview setting, thereby securing its position as the cor-
nerstone valuation technique for EQ-5D-5L valuation
studies.
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